Funian Li
P.R. China
Qingdao, 266000, China
Qingdao, 266000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Erratum: [Corrigendum] Mesenchymal stem cells expressing interleukin‑18 suppress breast cancer cells in vitro.
Journal: Experimental and therapeutic medicine
Published: August 21, 2023
Paired‑related homeobox 1 overexpression promotes multidrug resistance via PTEN/PI3K/AKT signaling in MCF‑7 breast cancer cells.
Journal: Molecular medicine reports
Published: November 25, 2019
A randomized multicenter phase II trial of mecapegfilgrastim single administration versus granulocyte colony-stimulating growth factor on treating chemotherapy-induced neutropenia in breast cancer patients.
Journal: Annals of translational medicine
Published: June 18, 2019
p53-independent role of MYC mutant T58A in the proliferation and apoptosis of breast cancer cells.
Journal: Oncology letters
Published: February 28, 2018
PRRX1 drives tamoxifen therapy resistance through induction of epithelial-mesenchymal transition in MCF-7 breast cancer cells.
Journal: International journal of clinical and experimental pathology
Published: January 12, 2018
Effect of miRNA-135b on proliferation, invasion and migration of triple-negative breast cancer by targeting APC
Journal: Zhonghua yi xue za zhi
Published: December 30, 2015
Mesenchymal stem cells expressing interleukin-18 inhibit breast cancer in a mouse model.
Journal: Oncology letters
Published: July 02, 2015
Role of transforming growth factor-β1 in epithelial-mesenchymal transition of mesothelial cells and its effect on peritoneal metastasis of gastric cancer
Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery
Published: February 07, 2015
Effect of interleukin-18 gene modified human umbilical cord mesenchymal stem cells on proliferation of breast cancer cell
Journal: Zhonghua yi xue za zhi
Published: October 15, 2014
Mesenchymal stem cells expressing interleukin-18 suppress breast cancer cells in vitro.
Journal: Experimental and therapeutic medicine
Published: June 07, 2014
Efficacy of combined therapy of goserelin and letrozole on very young women with advanced breast cancer as first-line endocrine therapy.
Journal: Endocrine journal
Published: May 30, 2013
Last Updated: 09/26/2026